Login Join us
BACK

Popular

Showing items 91-100 of 100

Policy & Advocacy
Business Group on Health Comments Regarding NPRM on ACA Reporting and 6055 TIN Solicitations

Topic: Policy & Advocacy

Tags: Plan Design & Administration, Affordable Care Act (ACA), Compliance,

Recap of Employer-only Sharing Call: Creating a Captivating Open Enrollment Experience

Topic: Benefits Strategy

Tags: Benefits Communication,

Articles & Guides
Global Brokers Call Summary: Statement of Work

Topic: Global

Tags: Global Benefits Management,

Policy & Advocacy
Departments Respond to Court Order with Proposed Rule on Federal Independent Dispute Resolution Fees

Topic: Policy & Advocacy

Tags: Surprise Billing,

Policy & Advocacy
Comments to CMS on a 2020 Proposed Medicare Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Other Issues

Topic: Policy & Advocacy

Tags: Payment & Delivery Reform,

Policy & Advocacy
Business Group and Other Stakeholders Request Guidance on HDHP Status and Pre-Deductible Preventive Care

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Articles & Guides
What Your CEO is Reading: Potential Impact of Alleged Generic Price Fixing

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Policy & Advocacy
Comment Letter on 2021 Notice of Benefit and Payment Parameters

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Policy & Advocacy
Senate Bill Would Impose 3-Day Limit on Initial Opioid Scripts

Topic: Policy & Advocacy

Tags: Leave Policy,

Policy & Advocacy
House Energy and Commerce Committee Passes 6 Bills Aimed at Increasing Generic Drug Competition

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Showing items91-100 of 100